St. Louis, MO 的 套細胞淋巴瘤 臨床試驗
8 項針對 套細胞淋巴瘤 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
招募中3 期
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- 還有 4 項
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
招募中1/2 期
- Washington University School of Medicine, St Louis
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Washington University School of Medicine, St Louis
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
招募中1 期
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Washington University, St. Louis, St Louis
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
招募中2 期
- Washington University, St Louis
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
招募中1/2 期
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, St Louis
其他城市的 套細胞淋巴瘤 試驗
- Houston, TX15 項研究
- Baldwin Park, CA15 項研究
- Durham, NC13 項研究
- Seattle, WA12 項研究
- New York City, NY12 項研究
- Milwaukee, WI12 項研究
- Boston, MA11 項研究
- Nashville, TN11 項研究
- Columbus, OH11 項研究
- Chicago, IL10 項研究
- Rochester, MN9 項研究
- Portland, OR9 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌64 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌50 項研究
- 癌症（所有類型）46 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。